Even if you aren’t a slave to a fitness tracker, the concept of walking 10,000 steps a day is ingrained as a general health ...

Moderna 's (NASDAQ: MRNA) stock fell by 13% on Sept. 12 upon the announcement of extensive cost cuts that would affect a ...

Until recently, the pharmaceutical industry remained relatively insulated from the simmering trade war between China and the ...

The research arm of Mercedes-Benz in North America, which is focused on delivering personalized, digital experiences for ...

Over $27 million in Department of Defense funding has been awarded for the New York-based Northeast Regional Defense ...

Researchers at multiple AViDD centers confirm that the NIH has offered a 1-year, no-cost extension, but it doesn’t come with ...

Beauty entrepreneur and mother Emma Lewisham shares a day in her life, from hosting international meetings for her eponymous ...

Dallas’ Almaden Genomics Launches New Data Management and Informatics Service Business Dallas-based Almaden Genomics—whose ...

David Pittman (left), who directs the Engineer Research and Development Center (ERDC) for the U.S. Army Corps of Engineers, ...

In the heart of Page, Arizona, R D’s Drive-In offers a classic, no-frills experience that locals swear by. This family-run burger joint serves up mouthwatering bites, but its real claim to fame is the ...

Now, let's get back to our question. Is the stock a buy or a sell? This depends a lot on your own particular investment ...

Moderna Inc (NASDAQ:MRNA) unveiled key updates at its annual R&D Day by reducing annual R&D spending by $1.1 billion by 2027, ...